Literature DB >> 12453725

Detection of aristolochic acid in Chinese phytomedicines and dietary supplements used as slimming regimens.

J-R Ioset1, G E Raoelison, K Hostettmann.   

Abstract

Over the last 10 years, numerous cases of intoxications, leading for the most part to end-stage renal failure, have been reported after consumption of slimming regimens made of Chinese herbal preparations. These intoxications were associated with species of the Aristolochia genus, such as Aristolochia fangchi (Aristolochiaceae), known to contain very nephrotoxic and carcinogenic metabolites named aristolochic acids. Several commercial dietary supplements, teas and phytomedicines used as slimming regimens were analysed for their aristolochic acid I content. A preliminary detection of this toxic compound was made by thin-layer chromatography. The presence of aristolochic acid I in these preparations was confirmed by a HPLC/UV-DAD/MS analysis. A quantitative determination of aristolochic acid I was also achieved in the incriminated preparations using both UV and MS detection. Out of 42 analysed preparations, four were found to contain aristolochic acid I and two were suspected to contain aristolochic acid derivatives. Immediate removal of these products from the Swiss market was called for.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12453725     DOI: 10.1016/s0278-6915(02)00219-3

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  15 in total

1.  Potential risks associated with the use of herbal anti-obesity products.

Authors:  Thomas Y K Chan
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

2.  A simple and selective detection method for aristolochic acid in crude drugs using solid-phase extraction.

Authors:  Takaomi Tagami; Akihiro Takeda; Akiko Asada; Airin Aoyama; Takahiro Doi; Masami Kawaguchi; Keiji Kajimura; Yoshiyuki Sawabe; Hirotaka Obana; Katsuhiro Yamasaki
Journal:  J Nat Med       Date:  2013-01-10       Impact factor: 2.343

Review 3.  Safety of drug therapies used for weight loss and treatment of obesity.

Authors:  Lisa L Ioannides-Demos; Joseph Proietto; Andrew M Tonkin; John J McNeil
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 4.  Aristolochic acid-associated cancers: a public health risk in need of global action.

Authors:  Samrat Das; Shefali Thakur; Michael Korenjak; Viktoriya S Sidorenko; Felicia Fei-Lei Chung; Jiri Zavadil
Journal:  Nat Rev Cancer       Date:  2022-07-19       Impact factor: 69.800

5.  A meta-analysis of medicinal plants to assess the evidence for toxicity.

Authors:  Sarah Chen; Amandio Vieira
Journal:  Interdiscip Toxicol       Date:  2010-06

6.  Simple and rapid analysis of aristolochic acid contained in crude drugs and Kampo formulations with solid-phase extraction and HPLC photodiode-array detection.

Authors:  Katsuhiro Yamasaki; Takaomi Tagami; Masami Kawaguchi; Masahiro Okihashi; Satoshi Takatori; Yoshikazu Sakagami; Setsuko Sekita; Motoyoshi Satake
Journal:  J Nat Med       Date:  2009-08-13       Impact factor: 2.343

7.  Isolation, Characterization and Quantity Determination of Aristolochic Acids, Toxic Compounds in Aristolochia bracteolata L.

Authors:  Abdelgadir A Abdelgadir; Elhadi M Ahmed; Mahgoub Sharif Eltohami
Journal:  Environ Health Insights       Date:  2011-02-27

8.  Aristolochic acid I induced autophagy extenuates cell apoptosis via ERK 1/2 pathway in renal tubular epithelial cells.

Authors:  Youjia Zeng; Xiao Yang; Juan Wang; Jinjin Fan; Qingyu Kong; Xueqing Yu
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

9.  A brief study of toxic effects of some medicinal herbs on kidney.

Authors:  Mohammad Asif
Journal:  Adv Biomed Res       Date:  2012-08-28

10.  Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003.

Authors:  Shu-Ching Hsieh; I-Hsin Lin; Wei-Lum Tseng; Chang-Hsing Lee; Jung-Der Wang
Journal:  Chin Med       Date:  2008-10-23       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.